Home | Business News | Browse by Publication | J | JCNN News Summaries

Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania.

Publication: JCNN News Summaries
Publication Date: 02-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Tokyo, Sept 2, 2009 - (JCN) - Ranbaxy Laboratories, India's largest pharmaceutical, and parent Daiichi Sankyo have announced that Terapia S.A., a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication Evista in Romania. This is the first time that Daiichi Sankyo and Ranbaxy are leveraging synergies generated...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from JCNN News Summaries
Kuraray Mediacal Obtains Approval for Artificial Bone Graft., September 02, 2009
Marubeni Secures Financing for Copper Mining Projects in Chile., September 02, 2009
SONY Selling More TVs than Estimated., September 02, 2009
SoftBank Seeking Partner in Taiwan., September 02, 2009
So-Net's Gamepot to License Livly Island to Taiwan's Soft-World., September 02, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.